An institutional holder
Filed with the SEC on · accession 0001167557-26-000152
HAE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. An institutional holder filed an amended Schedule 13G for Haemonetics Corp, indicating a change in its passive ownership position. The stock moved +4.7% by the first close after the filing.
An institutional holder filed an amended Schedule 13G for Haemonetics Corp, indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, share count, or ownership percentage.
Close before
$87.22
Aug 11, 2026
First close after
+4.72%
$91.34
5 trading days
+19.98%
$104.65
Since filing
+37.50%
$119.93
✦ Ask GOAX AI about this filing — what it means for HAE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for HAE?
Click hereHAE filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Haemonetics Corp, indicating a change in its passive ownership position. The filing text provided does not disclose the specific holder, share count, or ownership percentage.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
HAE closed at $87.22 before the filing and $91.34 on Aug 12, 2026 (+4.72%). Five trading days later: $104.65 (+19.98%).
Get alerts when HAE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days